OSCAR Human, Sf9

Osteoclast Associated, Immunoglobulin-Like Receptor Human Recombinant, Sf9
Shipped with Ice Packs
In Stock

Description

Immune Regulation

  • Antigen Presentation: OSCAR binds collagen motifs and facilitates antigen uptake in dendritic cells, promoting T-cell activation .

  • Inflammatory Signaling: Activation of OSCAR triggers TNF-α release from CCR2+ monocytes, exacerbating conditions like rheumatoid arthritis (RA) and atherosclerosis .

Bone Homeostasis

  • Osteoclastogenesis: OSCAR-FcRγ complexes provide co-stimulatory signals for osteoclast differentiation, mediated via integrin β3 subunits .

  • Disease Link: Elevated OSCAR levels in RA patients correlate with increased osteoclast differentiation and bone resorption .

Therapeutic Targeting

  • Inhibition Strategies: OSCAR-Fc fusion proteins block ligand interactions, reducing osteoclastogenesis in RA models .

  • Disease Models: Used to study atherosclerosis, chronic obstructive pulmonary disease (COPD), and inflammatory bone loss .

Functional Assays

  • ELISA Data: OSCAR-Fc binding to SP-D shows a dissociation constant (Kd) in the nanomolar range .

  • Cytokine Release: OSCAR activation in monocytes increases TNF-α secretion by 3- to 5-fold compared to controls .

Disease Relevance

DiseaseOSCAR RoleReference
Rheumatoid ArthritisUpregulated in synovial macrophages; enhances osteoclast differentiation
AtherosclerosisColocalizes with SP-D in plaque macrophages; promotes inflammation

Production and Quality Control

  • Expression: Optimized in Sf9 cells for high yield (0.25–0.45 mg/mL) .

  • Endotoxin Levels: <1 EU/µg, suitable for in vitro assays .

  • Validation: Confirmed via Western blot, flow cytometry, and functional assays .

Product Specs

Introduction
Osteoclast-associated immunoglobulin-like receptor isoform 6, or OSCAR, is a receptor for surfactant protein D found on human myeloid cells. OSCAR plays a role in the release of TNF-α from human CCR2+ inflammatory monocytes. This protein is involved in antigen presentation and the activation of dendritic cells. OSCAR is expressed on both preosteoclasts and mature osteoclasts. Patients with rheumatoid arthritis (RA) exhibit upregulation of OSCAR on monocytes, which correlates with increased proosteoclastogenic potential.
Description
Produced in Sf9 Baculovirus cells, OSCAR is a single, glycosylated polypeptide chain encompassing amino acids 19-282. It is fused to a 6 amino acid His Tag at the C-terminus, resulting in a protein with a total of 270 amino acids and a molecular mass of 29.2 kDa. On SDS-PAGE under reducing conditions, OSCAR appears as multiple bands between 40-57 kDa. It is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered colorless solution.
Formulation
OSCAR protein solution (0.25 mg/ml) is supplied in Phosphate Buffered Saline (pH 7.4) with 10% glycerol.
Stability
For short-term storage (2-4 weeks), store at 4°C. For extended storage, freeze at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Greater than 90.0% purity as determined by SDS-PAGE.
Synonyms

OSCAR, PIgR-3, PIGR3, hOSCAR, PIgR-3, Poly-Ig Receptor 3.

Source
Sf9, Baculovirus cells.
Amino Acid Sequence

DITPSVPPAS YHPKPWLGAQ PATVVTPGVN VTLRCRAPQP AWRFGLFKPG EIAPLLFRDV SSELAEFFLE EVTPAQGGSY RCCYRRPDWG PGVWSQPSDV LELLVTEELP RPSLVALPGP VVGPGANVSL RCAGRLRNMS FVLYREGVAA PLQYRHSAQP WADFTLLGAR APGTYSCYYH TPSAPYVLSQ RSEVLVISWE GEGPEARPAS SAPGMQAPGP PPSDPGAQAP SLSSFRPRGL VLQPLLPQTQ DSWDPAPPPS DPGVHHHHHH.

Q&A

What experimental approaches validate OSCAR-SP-D interactions in pulmonary studies?

OSCAR binds Surfactant Protein D (SP-D) through a conserved collagenous domain motif (GXPGPXGFXGXP) . Key validation steps include:

  • Motif Identification:

    • Perform BLAST-P searches using OSCAR's 9-12 amino acid binding sequence against the NCBI non-redundant protein database .

    • Use PAM30 substitution matrices with an expect threshold of 20,000 to account for short, imperfect matches.

  • Binding Assays:

    • Immobilize recombinant SP-D (2.5 μg/mL) on ELISA plates in 0.01M acetic acid .

    • Apply OSCAR-Fc fusion proteins (0.25 μg/mL) and quantify binding via anti-human IgG-HRP conjugates.

    • Include LAIR-1-Fc and irrelevant Fc proteins as negative controls to rule out nonspecific collagen interactions.

Table 1: Key Parameters for OSCAR-SP-D Binding Experiments

VariableOptimal ConditionControl Consideration
SP-D immobilization4°C overnight in acetic acidBSA-coated wells
OSCAR-Fc concentration0.25 μg/mLLAIR-1-Fc fusion proteins
Blocking buffer5% BSA in TBSValidate with anti-OSCAR mAbs

How do Sf9 cells enhance OSCAR-Fc fusion protein production?

Sf9 cells (derived from Spodoptera frugiperda) enable high-yield post-translational modification of OSCAR-Fc via baculovirus vectors:

  • Vector Design: Clone OSCAR’s extracellular domain into pFastBac vectors with an IgG1 Fc tag using XhoI/XbaI restriction sites .

  • Transfection: Use Cellfectin II reagent with 2 μg plasmid DNA per 1×10^6 cells. Harvest supernatants at 72 hr post-infection.

  • Quality Control:

    • Confirm disulfide bond formation via non-reducing SDS-PAGE.

    • Test endotoxin levels (<0.1 EU/μg) using LAL assays to prevent immune cell activation artifacts .

How to resolve contradictions in OSCAR binding affinity measurements across studies?

Discrepancies in reported Kd values (e.g., 10 nM vs. 150 nM) often stem from:

Technical Factors:

  • Collagen Preparation: Rat tail collagen I batches vary in telopeptide content, altering OSCAR binding. Use mass spectrometry to verify collagen integrity.

  • SP-D Isoforms: Trimeric vs. dodecameric SP-D assemblies show 8-fold differences in OSCAR avidity . Characterize oligomerization state via gel filtration chromatography.

Biological Variables:

  • Monocyte Subtypes: Inflammatory CCR2+ monocytes exhibit 3× higher OSCAR surface density than resident subsets . Use FACS with CD14/CD16/CD192 markers to stratify populations.

Statistical Approach:

  • Apply mixed-effects models to account for donor-to-donor variability in primary cell assays.

What methodologies optimize Sf9 cell systems for large-scale OSCAR mutagenesis studies?

High-throughput OSCAR mutagenesis requires:

  • Bacmid Engineering:

    • Use Tn7 transposition with >90% efficiency checks via blue/white screening.

    • Implement site-saturation mutagenesis at collagen-binding residues (positions 42–55).

  • Expression Troubleshooting:

    • For insoluble proteins: Add 2 mM glutathione redox buffer during infection.

    • For low yields: Test multiplicity of infection (MOI) from 0.1–5 and harvest at 48–96 hr intervals.

Table 2: Sf9 Culture Optimization Matrix

ParameterLow Yield ScenarioHigh Purity Scenario
Cell density at infection2×10^6 cells/mL1.5×10^6 cells/mL
Serum concentration1% FBS (cost-effective)0% SFM (protein-free)
Harvest timepoint72 hr (balance)96 hr (mature glycosylation)

How to model OSCAR-SP-D interactions in atherosclerotic microenvironments?

Advanced co-culture systems address this:

  • 3D Plaque Model:

    • Seed human aortic endothelial cells (HAECs) on collagen I scaffolds (2 mg/mL).

    • Add THP-1 monocytes pre-treated with 100 ng/mL SP-D for 24 hr.

  • Readout Optimization:

    • Quantify TNF-α via MSD U-PLEX (1 pg/mL sensitivity) to detect low-grade inflammation.

    • Image OSCAR/SP-D co-localization using Airyscan confocal microscopy (63×/1.4 NA oil lens).

What computational tools predict novel OSCAR-binding collagen motifs?

Beyond BLAST, machine learning pipelines improve prediction accuracy:

  • Feature Extraction:

    • Calculate amino acid flexibility with DisoMine and collapsibility via Collagen Analysis Tool (CAT).

  • Model Training:

    • Train Random Forest classifiers on 28 known OSCAR-binding vs. 100 non-binding collagen sequences .

    • Validate using 5-fold cross-validation (AUC >0.85 required).

Product Science Overview

Introduction

The Osteoclast Associated, Immunoglobulin-Like Receptor (OSCAR) is a protein encoded by the OSCAR gene. This receptor is a member of the leukocyte receptor complex protein family and plays a crucial role in the regulation of both innate and adaptive immune responses . OSCAR is specifically expressed in preosteoclasts and mature osteoclasts, making it an important regulator of osteoclast differentiation .

Structure and Function

OSCAR is an IgG-like receptor that acts as a costimulatory receptor for osteoclast differentiation through the activation of NFATc1 . Osteoclasts are multinucleated cells responsible for bone resorption, a process essential for bone homeostasis . The receptor’s expression is highly conserved across different species, highlighting its significance in bone biology .

Role in Osteoimmunology

OSCAR has been identified as a key mediator in osteoimmunology, the study of the interface between the skeletal and immune systems . It plays a role in oxidative stress-mediated atherogenesis and monocyte adhesion . The receptor’s involvement in these processes underscores its importance in both bone health and immune regulation.

Human Recombinant OSCAR (Sf9)

The human recombinant form of OSCAR, produced in Sf9 insect cells, is used in various research applications. This recombinant protein allows scientists to study the receptor’s function and its role in osteoclastogenesis and immune responses in a controlled environment.

Clinical Implications

Mutations or dysregulation of the OSCAR gene have been associated with various diseases, including malignant leptomeningeal neoplasm and leptomeninges sarcoma . Understanding the function and regulation of OSCAR can provide insights into potential therapeutic targets for these conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.